|
WWTR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.34790000000129E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64075999999902E-05 |
| Normal-vs-Stage2 |
7.407400E-04 |
| Normal-vs-Stage3 |
3.093000E-01 |
| Normal-vs-Stage4 |
1.278210E-01 |
| Stage1-vs-Stage2 |
8.996200E-01 |
| Stage1-vs-Stage3 |
1.668380E-01 |
| Stage1-vs-Stage4 |
8.725800E-01 |
| Stage2-vs-Stage3 |
2.250800E-01 |
| Stage2-vs-Stage4 |
9.364600E-01 |
| Stage3-vs-Stage4 |
4.893400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.15870000000296E-05 |
| Normal-vs-AfricanAmerican |
2.764800E-04 |
| Normal-vs-Asian |
1.963790E-03 |
| Caucasian-vs-AfricanAmerican |
7.312800E-01 |
| Caucasian-vs-Asian |
3.720200E-01 |
| AfricanAmerican-vs-Asian |
3.005400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77856999999948E-05 |
| Normal-vs-Female |
1.522050E-02 |
| Male-vs-Female |
1.282440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.564400E-04 |
| Normal-vs-Extreme_Weight |
1.72752999999526E-05 |
| Normal-vs-Obese |
9.558400E-03 |
| Normal-vs-Extreme_Obese |
2.098100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.705600E-01 |
| Normal_Weight-vs-Obese |
9.717900E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.762400E-01 |
| Extreme_Weight-vs-Obese |
6.929900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.944400E-01 |
| Obese-vs-Extreme_Obese |
5.761200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.971830E-01 |
| Normal-vs-Age(41-60Yrs) |
7.037700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.24349999999873E-06 |
| Normal-vs-Age(81-100Yrs) |
1.00110000000875E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.833000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.771600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.027250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.938100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.375700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.644000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.164300E-04 |
| Normal-VS-Type2 PRCC |
4.7843999999575E-06 |
| Normal-VS-KIRP CIMP |
6.110600E-01 |
| Normal-VS-Unclassified PRCC |
9.509800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.062800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.794500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.346400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.030500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.764100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.449390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55520000000698E-07 |
| Normal-vs-N1 |
7.603200E-01 |
| Normal-vs-N2 |
7.721800E-01 |
| N0-vs-N1 |
2.878200E-02 |
| N0-vs-N2 |
5.331400E-01 |
| N1-vs-N2 |
8.430600E-01 |
|
|
